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Follicular Helper T Cells in Systemic 
Lupus erythematosus
Sun Jung Kim, Kyungwoo Lee and Betty Diamond*
The Feinstein Institute for Medical Research, Northwell Health, New York, NY, United States
CD4+ follicular helper T (Tfh) cells constitute a subset of effector T cells that participate in 
the generation of high-affinity humoral responses. They express the chemokine receptor 
CXCR5 and produce the cytokine IL-21, both of which are required for their contribution 
to germinal center formation. Uncontrolled expansion of Tfh cells is observed in various 
mouse models of systemic autoimmune diseases and in patients with these diseases. In 
particular, the frequency of circulating Tfh is correlated with disease activity and anti-DNA 
antibody titer in patients with systemic lupus erythematosus. Recent studies reveal func-
tional diversity within the Tfh population in both humans and mice. We will summarize 
here the molecular mechanisms for Tfh cell generation, survival and function in both 
humans and mice, and the relationship between Tfh cells and autoimmune disease in 
animal models and in patients.
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iNTRODUCTiON
It has long been known that T cells are required for successful humoral immune responses (1). Upon 
stimulation, CD4+ naïve T cells differentiate into T helper (Th) 1, Th2, Th17, follicular helper T (Tfh), 
and regulatory T (Treg) cells. Each subset requires distinct activation signals and cytokine milieu 
during activation; each expresses a unique transcriptional profile with a unique master regulator 
and distinct effector cytokines; and each subset serves a different function in the immune response. 
Activation of naïve CD4+ T cells by antigen-presenting cells (APCs) together with IL-6 and IL-21 
induces Tfh cells. Development of Tfh cells is required for an optimal antibody response, mainly 
through activation and maintenance of the germinal center (GC) response. Tfh cells express the mas-
ter transcription factor, B cell lymphoma 6 (BCL6). This transcription factor distinguishes the Tfh 
compartment from other T helper cell subsets, and is required for the maintenance of their effector 
function in lymphoid organs (2–7). Activation of STAT3 is also important for Tfh differentiation as 
it upregulates BCL6 (8). STAT3-deficient mice have a diminished Tfh compartment and an increased 
Th1 response. The expression of BCL6 is antagonized by the transcriptional repressor, B lymphocyte-
induced maturation protein 1 (BLIMP1) (4). Induction of BCL6 and the downregulation of BLIMP1 
appear to be equally important in human Tfh differentiation (4, 8).
Follicular helper T cells express a unique set of effector molecules that are critical for their 
function. High expression of CXCR5 with downregulation of CCR7 has been shown to be impor-
tant for migration of Tfh into the B cell follicle (9). Inducible co-stimulator (ICOS), programmed 
cell death protein 1 (PD-1), and CD40L are also expressed on Tfh cells and these molecules are 
required for activation of B  cells (6, 10–14). Mice lacking CD40 or CD40L exhibit disrupted 
GC responses and impaired long-term memory (12). ICOS–ICOSL signaling is essential for a 
sustained T:B interaction; consequently, loss of either molecule impairs GC B cell survival and 
plasma cell differentiation (15). PD-1 deficiency does not affect the number of GC B cells and the 
early antibody response; however, engagement of PD-1 on Tfh cells and PD-L1/2 on GC B cells 
is critical for the development of long-lived plasma cells (13). Tfh cells produce high amounts of 
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IL-21 and IL-4 which are required for proliferation of B cells 
and immunoglobulin class switching (6, 14). Blockade or defi-
ciency of these effector molecules abrogates the generation of 
an effective humoral response.
iNDUCTiON PROGRAM OF Tfh CeLLS
The immediate precursor of Tfh cells is not fully described. Initial 
studies identified the cytokines, IL-21 and IL-6, as key molecules 
in triggering Tfh cell differentiation. Engagement of TCR on naïve 
CD4+ T cells with peptide/MHC II on APCs together with IL-21 
induces expression of CXCR5 and a low level of BCL6 expression 
in  vivo (16, 17). Both IL-6 and IL-21 can induce Bcl6 mRNA 
in vitro (5); both activate cells through the STAT3 pathway (8, 16). 
IL-6 and IL-21 can trigger the early Tfh differentiation program 
in CD4+ T cells, but an absolute requirement for IL-6 and IL-21 
has been challenged. IL-6−/−, IL-21−/−, or IL-21R−/− mice develop 
Tfh cells normally following immunization with protein antigen 
or viral infection (18, 19). Although the triggering signals for 
first induction of BCL6 and CXCR5 in Tfh cells are not fully 
understood, once T cells acquire a “CXCR5loBCL6lo Tfh signature 
(pre-Tfh),” some will migrate to the T cell–B cell border (9, 20). 
A second transcription factor, c-MAF, is induced concomitantly 
with BCL6 (21). C-MAF has also shown to induce CXCR5. BCL6 
and c-MAF cooperatively induce ICOS, PD-1, and CXCR4, sug-
gesting both molecules orchestrate a core transcriptional program 
in Tfh cells (22).
CXCR5loBCL6lo pre-Tfh cells interact with cognate B cells at 
the T–B zone to induce a high level of BCL6 and CXCR5. This 
allows stable localization of the cells in follicles and sustains 
mature Tfh cell differentiation (4, 23). Signaling from a homodi-
meric interaction of signaling lymphocytic activation molecule 
(SLAM)-associated protein (SAP) (SH2D1A) on B  cells leads 
to induction of the SLAM family receptor, CD84, promoting 
stable T:B interactions (23, 24). In the absence of SAP, pre-Tfh 
cells develop normally, but fail to move into the GC and mature 
to GC-Tfh cells (24). This B cell-dependent Tfh differentiation 
can be bypassed by chronic immune activation. Mice lacking 
MHC II expression on B cells develop normal GC-Tfh cells fol-
lowing repeated immunization (25) or chronic viral infection 
(26). These observations suggest that while B  cells maybe the 
major APC important in Tfh differentiation, B-independent 
Tfh maturation can occur when a high and sustained amount 
of antigen is present. An ICOS–ICOSL interaction between 
pre-Tfh and B  cells is required for maintaining a high level 
of CXCR5 or BCL6 in Tfh cells. ICOS signaling activates the 
PI3K pathway and selective abrogation of ICOS–PI3K signal-
ing dramatically reduces Tfh differentiation (27). ICOS–PI3K 
signaling keeps pre-Tfh cell motile at the T  cell–B  cell border 
to facilitate cognate T:B interactions (28). It also augments IL-4 
and IL-21 transcription (27, 29). The importance of the PI3K 
pathway during Tfh differentiation is demonstrated in studies 
of mice with CD4-specific deletion of a microRNA miR 17-92. 
miR17-92 is induced at an early stage of Tfh cell differentiation 
and regulates PI3K signaling intensity through downregulation 
of phosphatase, PHLPP2. T  cells with a deletion of miR17-92 
show a severe reduction in Tfh differentiation (30).
NeGATive ReGULATiON OF Tfh BY 
FOLLiCULAR ReGULATORY T (Tfr) CeLLS
The interaction between Tfh cells and B cells (GC B cells and plasma 
cells) needs to be precisely regulated to ensure proper immune 
activation and to limit excessive inflammation and autoimmun-
ity. Tfr cells, a recently identified Treg subset, migrate to the GC 
and inhibit Tfh cells and GC B cells (31, 32). Differentiation of 
Tfr is mediated by recognition of antigens presented on DCs in 
lymphoid organs (31). Signals from the co-stimulatory molecules 
CD28 and ICOS are essential for Tfr differentiation as Cd28−/− 
and Icos−/− mice lack Tfr cells (32, 33). Engagement of CTLA-4 on 
Tfr cells with B7.1 and B7.2 on APCs is critical for their suppres-
sive mechanism (34–36). In contrast, Tfr cells express high levels 
of PD-1 which mitigates the suppressive function of Tfr cells. 
Pdcd1−/− Tfr cells suppress antibody production more potently 
in vitro and in vivo (33). Tfr cells express CXCR5 which guides 
them to the GC (32). Tfr, like Tfh cells, also express the canonical 
transcription factor, BCL6, although the level of BCL6 is lower 
than in Tfh cells. In addition to BCL6, Tfr cells express FOXP3 
and BLIMP1, which are not expressed in Tfh cells (37).
The Tfh:Tfr ratio controls antibody responses. In the basal-
state, Tfr cells constitute approximately 50% of all CD4+CXCR5+ 
T cells, resulting in a 1:1 ratio of Tfh:Tfr cells. Under stimulatory 
conditions including immunization or infection, Tfh cells expand 
resulting in a lower proportion of Tfr cells. A proper differentiation 
of Tfr is critical for immune tolerance as mice with Tfr deficiency 
(Bcl6fl/flFoxp3-CRE) develop spontaneous autoimmune disease 
(38). A critical role for Tfr but not other Treg cells in antibody 
production was confirmed in an adoptive transfer study. Transfer 
of Tregs from Tfr-deficient Bcl6−/− or wild-type mice together 
with CD4+ T cells into Tcrb−/− mice resulted in an expansion of 
Tfh cells and higher antibody responses (37).
Tfh iN B CeLL ACTivATiON AND iN GC 
AND iN THe eXTRAFOLLiCULAR SPACe
The primary function of Tfh cells is to help activation and dif-
ferentiation of antigen-specific B  cells in a protective immune 
response. This requires engagement of surface molecules (CD40L 
and ICOS) on Tfh cells with their ligands on B cells (CD40 and 
ICOSL, respectively) and secretion of cytokines (IL-21 and IL-4) 
from Tfh cells (6, 14). GCs are the primary site of B cell affin-
ity maturation and class switching. Tfh cells regulate GC size, 
restrict low affinity B  cell entry into the GC, and support and 
select high-affinity B cells during affinity maturation within the 
GC (4, 13, 29, 39). The quality and quantity of help provided by 
Tfh cells regulates B cell clonal expansion. As restriction of T cell 
help to high-affinity B cells is required for affinity maturation in 
GCs (40), proper regulation of Tfh determines the outcome of 
the GC response.
Signals from Tfh cell to B  cells are required for both the 
generation and the maintenance of GCs. To initiate GC B  cell 
differentiation, Tfh cells induce expression of BCL6 (master tran-
scription factor for GC B cells) in activated B cells. The precise 
mechanism how the initial BCL6 expression occurs is complex 
and not clearly understood; however, signals from the IL-21R are 
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an important factor for BCL6 expression in B cells (18, 41). Tfh 
cells also provide proliferation and survival signals to GC B cells 
via multiple pathways, including CD40L, PD-1, IL-21, and IL-4 
(41–44). The CD40–CD40L interaction is important in survival 
of GC B cells partly because it also helps to induce BCL6 (45). 
Combinatorial signals by CD40L and IL-21 or CD40L and IL-4 
maintain GC B cell proliferation. Although PD-1 is known to pro-
vide a potent inhibitory signal to T cells (46), deficiency in PD-1 
or PD-L1/2 reduces B cell differentiation (13). Formation of GCs 
is normal in the absence of PD-1 or PD-L1/2, but maintenance 
of GCs is severely affected due to an increase in apoptosis of GC 
B cells. The interaction between ICOS on Tfh cells and ICOSL 
on B cells is important for both B cells and Tfh cells (10, 11). The 
ICOS–ICOSL signaling is essential for the sustained T:B interac-
tion, consequently influencing affinity maturation of GC B cells, 
survival, and plasma cell differentiation (15). Cognate interaction 
between Tfh and GC B cells is a key mechanism for selection of 
high-affinity GC B cells and for memory B cells or plasma cells 
(47, 48). Tfh cells regulate plasmablast emergence out of GC dur-
ing the early stages of GC reaction. IL-21 produced from Tfh cells 
and TNFSF13 (APRIL) produced form podoplanin+ CD157hi 
fibroblastic reticular cells are the two main factors for this process 
(49). IL-21 is highly expressed by Tfh cells and is the most potent 
cytokine for driving plasma cell differentiation (2, 50). Both IL-21 
and IL-4 are class switch factors for IgG1 (51, 52).
Follicular helper T cells play a key role in B cell differentiation 
into antibody-producing cells outside GCs as well. Recent studies 
demonstrate that there are different subsets of Tfh cells in humans 
and mice. BCL6+ Tfh cells are required for B  cell priming for 
extrafollicular antibody production in a T-dependent immune 
response (53). In contrast to the conventional Tfh cells, they 
express PD-1 but not CXCR5 and appear before GC formation 
at the T cell–B cell border. IL-21 produced from these PD-1+ Tfh 
cells support B  cell activation and differentiation to antibody-
producing cells.
RePeRTOiRe OF Tfh
How the repertoire of Tfh cells is determined is not well under-
stood, and an altered repertoire of Tfh cells can contribute to the 
development of autoimmune diseases. Our recent study demon-
strated that the repertoire of Tfh is different in lupus-prone mice 
compared to healthy control mice, and the alteration of Tfh reper-
toire is closely associated with lupus development (54). This study 
suggests that not only the number of Tfh cells, but also the antigenic 
specificity of Tfh cells is likely essential to immune tolerance.
Sets of antigenic peptides presented by APCs, including 
thymic epithelial cells, dendritic cells (DCs), and B cells are likely 
to influence the repertoire of T cells emerging from the thymus. In 
the periphery, affinity and duration of interaction between TCR 
and peptide/MHC II influences DCs to induce the activation of 
T cells and modulate the repertoire of T cells (25, 55). Cathepsin 
S (CTSS) is a major endoprotease cleaving the invariant chain 
from MHC II molecules and also cleaving exogenous antigens 
(54). Increased activity of CTSS in DCs is involved in regulation 
of the Tfh repertoire (54). In one study, the antigenic specificity 
of Tfh cells was investigated during a polyclonal B cell response 
in mice (56). Polyreactive Tfh cells are generated and individual 
antigen-specific Tfh cells show distinct cytokine profiles. A study 
of human Tfh shows that CXCR5+ circulating memory-like Tfh 
cells reactive with influenza protein preferentially recognize 
peptide epitopes from hemagglutinin, while CXCR5− non-Tfh 
preferentially recognize nucleoprotein (57). This study suggests 
that different effector T cell subsets may activate distinct B cells. 
Together, these observations, while limited, support an important 
role for the TCR repertoire of Tfh cells in autoreactive B cell selec-
tion and/or activation.
HUMAN Tfh
Human Tfh cells are characterized in tonsil by high expression of 
CXCR5 and ICOS (58). These CXCR5hiICOShi cells reside in follicles 
and induce B cells to become antibody-secreting plasma cells, which 
is a hallmark of bona fide Tfh cells. In healthy individuals, tonsillar 
CD4+ T cells contain distinct populations according to the expres-
sion of CXCR5 and ICOS, including CXCR5hiICOShi (GC-Tfh), 
CXCR5loICOShi, CXCR5loICOSlo, and CXCR5−ICOS−. These 
subpopulations of Tfh cells display differential activation of B cells. 
CXCR5hiICOShi Tfh cells effectively activate and induce antibody 
production of GC-B cells (IgD−CD38+CD19+) and memory B cells 
(IgD−CD38−CD19+) but not naïve B  cells (IgD+CD38−CD19+) 
(58, 59). CXCR5loICOSlo Tfh cells show robust proliferation and 
differentiation of naïve B  cells and memory B  cells but not GC 
B  cells (60). Neither CXCR5−ICOS− Tfh nor CXCl5loICOShi Tfh 
cells show B cell activation activity. Each subpopulation of Tfh cells 
also produces a distinct pattern of cytokines. Upon co-culture with 
B cells or stimulated by anti-CD3/28, CXCR5hiICOShi GC-Tfh cells 
secrete high level of IL-21 and CXCL13 but low level of IL-10 and 
IL-4, CXCR5loICOSlo Tfh cells secrete high levels of IL-21 and IL-10 
with low level of IL-4, and CXCR5loICOShi Tfh cells secrete high 
level of IL-17A instead of IL-21 and IL-10. These studies suggest 
each Tfh population possesses a unique B cell activation capacity.
B  cell lymphoma 6-expressing extrafollicular Tfh cells have 
been identified in tissues and in blood (60, 61). Tfh cells identified 
in blood are different from tonsillar Tfh cells phenotypically and 
functionally. Circulating Tfh cells do not have same patterns of 
surface markers (CXCR5, ICOS, and PD-1) as tonsillar Tfh cells. 
Recent studies suggest that blood CXCR5+ CD4+ T cells represent 
a memory compartment of Tfh lineage cells. Extensive analysis 
of these cells revealed functionally and phenotypically distinct 
subsets, identified by expression of ICOS, PD-1, CCR7, CXCR3, 
and CCR6. While the expression of BCL6 and ICOS is high in 
tonsillar GC-Tfh cells, both ICOS and BCL6 protein expression 
is low in blood Tfh cells (61, 62). Less than 1% of blood CXCR5+ 
Tfh cells are ICOS+ and PD-1hi in healthy individuals (63, 64). The 
majority of CXCR5+ Tfh cells does not express ICOS and can be 
subsetted based on CXCR3, CCR6, and CCR7 expression, and, as 
mentioned above, each subgroup activates distinctive B cell sub-
sets and expresses different gene expression profiles (Figure 1). 
The CXCR3+ CCR6− subset (Tfh1) expresses the transcription 
factor T-bet and produces IFNγ; the CXCR3− CCR6− subset 
(Tfh2)expresses GATA3 and produces IL-4, IL-5, and IL-13; 
and the CXCR3− CCR6+ subset (Tfh17) expresses RORγt and 
produces IL-17A and IL-22 (61). All subsets of Tfh cells produce 
A B
FiGURe 1 | Subsets of circulating memory follicular helper T (Tfh) cells and their B cell activation. (A) The circulating CXCR5+ memory Tfh subsets. The minor 
CXCR5+ CD4+ T cells (1–5% of CXCR5+CD4+CD4+ T cells) express high levels of inducible co-stimulator (ICOS) and programmed cell death protein 1 (PD-1) and 
consist of CXCR3-positive or CXCR3-negative populations. The majority of CXCR5+ CD4+ T cells are low to negative in expression of ICOS and PD-1. These  
cells are subgrouped into Tfh1, Tfh2, and Tfh17 based on their chemokine receptor expression. These five subsets of Tfh cells express B cell lymphoma 6 as a 
master transcriptional regulator, and also express subset-specific transcription factors, effector cytokines, and activate naïve B cells to antibody-secreting cells.  
(B) CXCR5− CD4+ T cells [peripheral helper T (Tph)] which express high level of PD-1 exhibit strong B cell activation. These Tph cells developed under inflamed 
conditions and are found in both inflamed tissue and blood. Solid color indicates high level of expression and patterned color indicates low level of expression.
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IL-21 but not all induce B cells to secrete immunoglobulin; each 
subset has a distinct capacity for B cell activation. Naïve B cells 
can be stimulated by Tfh2 and Tfh17 but not CXCR3+ Tfh1 cells 
(61). Tfh2 cells promote IgG and IgE, while Tfh17 cells efficient 
inducers of IgG and IgA production. These studies suggest differ-
ent Tfh subsets regulate Ig class switching these subsets appear to 
exist in humans but not in mice.
The mechanism of human Tfh cell differentiation is actively 
being investigated. Human Tfh cells are differentiated from naïve 
CD4+ T cells, however, the critical signals and effector molecules 
are not fully understood. The plasticity among CD4+ helper T cell 
subsets is also poorly understood. Recent in vitro studies identi-
fied some molecules which influence human Tfh differentiation. 
Initial studies demonstrated that DCs can induce differentiation 
of Tfh cells from naïve CD4+ T  cells from human peripheral 
blood mononuclear cell (PBMCs) or from cord blood. Among 
the cytokines which are produced from activated DCs, IL-12 
is the most efficient cytokine to induce Tfh-related molecules 
(CXCR5, ICOS, and IL-21) and Tfh-related transcription factors 
(BCL6, BATF, and cMAF) (65). Another study found IL-12 most 
efficiently induced Tfh cells to produce IL-21 to activate B cells to 
become antibody-secreting cells (66). Surprisingly, these studies 
found that the Tfh-inducing cytokines in mouse, IL-6 or IL-21, 
are less efficient in the human system. IL-12 mediated human 
Tfh cells contain classical Th1 phenotypes, displaying a mixed 
population of IL-21+IFNγ− Tfh and IL-21+IFNγ+ Tfh cells. The 
importance of IL-12 in Tfh cell differentiation is also supported 
by the studies of patients with impaired IL-12 signaling. Patients 
with deficiency in IL-12Rβ1, TYK2, STAT3, but not STAT1 
exhibit compromised IL-12-induced expression of IL-21 by 
CD4+ T cells (67). Although IL-12/STAT3 axis is critical for IL-21 
and BCL6 expression, it is a dispensable for ICOS expression. 
Defects in generating Tfh cells from STAT3 mutant CD4+ T cells 
could contribute to the impaired T-dependent humoral immune 
responses observed in patients with STAT3 mutations (68).
Another cytokine, TGFβ, was shown to have a unique function 
in human Tfh cell differentiation (69). TGFβ and IL-12 together 
specifically down-regulate the level of BLIMP1 in Tfh cells. This 
regulatory mechanism is not shared by mouse Tfh cells. TGFβ 
also induces CXCL13 expression in human naïve CD4+ T cells 
(70), and, therefore, may contribute to the accumulation of T and 
B cell aggregates (ectopic GCs) in inflammatory tissues (71).
Activin A is an inducible molecule that is broadly expressed 
in immune cells. Signals via CD40 and toll-like receptors induce 
DCs to upregulate Activin A expression (72); Activin A induces 
human naïve CD4+ T cells to produce CXCL13 and differenti-
ate into Tfh cells in vitro (73). Therefore, Activin A may be also 
involved in Tfh differentiation especially under inflammatory 
conditions. A recent study on systemic lupus erythematosus 
(SLE) suggests the involvement of OX40L+ monocytes and DCs 
in Tfh production. The frequency of OX40L+ monocytes corre-
lated with disease activity and the frequency of ICOS+ PD-1+ Tfh 
cells in blood (74). TNFSF4, the gene encoding OX40L, has been 
determined by GWAS to have risk alleles in SLE, rheumatoid 
arthritis (RA), and multiple sclerosis (75), further suggesting an 
involvement of OX40 and OX40L interaction mediated Tfh path-
way in disease conditions. The molecular mechanisms by which 
naïve human CD4+ T cells differentiate to Tfh cells or maintain 
Tfh characteristics remain largely unknown.
ReLevANCe TO AUTOiMMUNiTY
Helper T  cells are required for a protective immune response 
and for the development of autoantibodies (76). Development 
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of autoantibodies is abrogated by genetic deletion of MHC II 
in CD4+ T cells in the B6. lpr lupus mouse model (77). Helper 
T  cell activity, especially Tfh cell activity, directly correlates 
with GC formation (78–80). Abnormalities in Tfh cells (Tfh 
cell accumulation or functional alteration of Tfh cells) have 
been observed in various models of autoimmune diseases. In 
sanroque mice, the number of Tfh cells is increased with the 
hyperactive ICOS signaling and excessive production of IL-21, 
leading to the development of spontaneous GC formation and 
lupus-like autoimmune phenotypes (3, 81, 82). Roquin has been 
shown to post-transcriptionally regulate the expression of ICOS 
and OX40, which are highly expressed by Tfh cells (58, 81, 83). 
CD4+ T cells lacking Roquin overexpress ICOS and OX40, pro-
moting Tfh cell differentiation. Blocking ICOS/ICOS-L or CD40/
CD40L interactions ameliorates disease progression in autoim-
mune mouse models (84, 85). High serum levels of IL-21 were 
also detected in BXSB-Yaa mice (2), and blockade of the IL-21/
IL-21R pathway slows the progression of lupus by decreasing 
lymphocyte activation and circulating IgG1 levels in BXSB-Yaa 
mice (86). These data demonstrate IL-21 as a key molecule for 
B cell differentiation to plasma cells. In this model, both follicular 
and extrafollicular T  cells are important producers of IL-21. 
Another SLE model, MRL/lpr mice, has increased extrafollicular 
ICOShiPSGL1lo CD4+ T  cells in secondary lymphoid organs. 
These cells are the primary source of CD40L and IL-21 supporting 
extrafollicular IgG plasmablasts (10). CD40L expressed by Tfh 
cells contributes to activation of B cells in autoimmune animal 
models. Antigen-specific extra Tfh cells which share phenotypic 
characteristics with Tfh also mediate IgG secretion through IL-21 
in a CD40L-dependent manner (10). Autoreactive Tfh cells have 
been observed in K/BxN mice, too. In this mice, self-reactive 
CD4+ T cells escape clonal deletion in the thymus and appear in 
periphery. The primed self-reactive CD4+ T cells help B cells to 
produce pathologic antibodies (87). Tfh cells have been shown to 
contribute to the pathogenesis of lupus through ICOS–B7RP-1 
pathway in NZB/NZW F1 mice (88). Abnormalities in Tfh cells 
are also observed in mice with genetic manipulations in 
non-T  cells. Mice with BLIMP1-deficient DCs spontaneously 
develop lupus-like phenotypes in a gender-specific manner, and 
these mice have increased Tfh cells and GC B cells (89). This study 
also shows that an increased proinflammatory cytokine, IL-6 
from the BLIMP1-deficient DCs facilitates Tfh differentiation 
as haplosufficiency for IL-6, prevents lupus-related phenotypes 
including Tfh cells.
There are multiple lines of evidences showing that aberrant Tfh-
cell and GC responses are associated with human SLE. The major-
ity of IgG+ autoantibodies in patients are somatically mutated, 
an observation consistent with an involvement of GCs, the site 
of action of Tfh (90, 91). In lupus nephritis lesions, Tfh-like 
cells expressing ICOS, PD-1, BCL-6, and IL-21 were observed, 
forming ectopic GCs (92). Furthermore, an increased population 
of circulating CXCR5+ICOS+PD-1+ Tfh cells was identified in 
a subset of SLE patients; this increase correlated with disease 
activity but not necessarily with the titer of anti-DNA antibodies 
(93, 94). ICOS+PD-1+ Tfh cells secrete high levels of IL-21, and 
a strong correlation between the expression of ICOS or PD-1 
and plasmablast number has been observed. The differential 
expression of ICOS, PD-1, and CCR7 further defines subpopula-
tions within the subsets (recently activated: ICOS+PD-1+CCR7lo 
and quiescent: ICOS−PD-1−CCR7hi) (62, 63). Other studies 
employing a combinatorial analysis of chemokine receptors 
(CXCR3 and CCR6) have defined three major subsets (Tfh1, 
Tfh2, and Tfh17) (61, 69). These analyses identified a relative 
dominance of Tfh2 and/or Tfh17 subsets over Tfh1 in systemic 
diseases, including SLE (93, 95), IgG4-related disease (96), and 
organ-specific diseases such as [Sjogren’s syndrome (97), RA 
(98, 99), and autoimmune thyroid disease (100)], and the neu-
rological diseases [myasthenia gravis (101), multiple sclerosis 
(102), and neuromyelitis optica (103)]. The alterations in Tfh 
subsets often positively correlated with disease activity and/or 
serum autoantibody titer, and with the frequency of circulating 
plasmablasts. These observations support the association of an 
expanded Tfh response with the pathogenesis of human autoim-
mune diseases; however, how the increased Tfh response leads to 
activation of autoreactive B cells is not elucidated in humans yet.
A recent study identified a new PD-1hi helper T cell subset in 
peripheral tissue [peripheral helper T (Tph) cells] from patients 
with RA (104). Tph cells are expanded in inflamed joint and 
blood from RA patients and display unusual biological features. 
They are programmed to infiltrate part of the inflamed body 
(CCR2+), and stimulate B  cells to produce antibodies (IL-21 
and CXCL13) in situ. In contrast to CXCR5+ Tfh cells, Tph cells 
exhibit a unique profile of molecules; CXCR5− but BLIMP1hi 
(high ratio of BLIMP1:BCL6) and PD-1hi (104). This finding 
expands the spectrum of T cells that are associated with inflam-
matory diseases; it will be interesting to investigate whether 
PD-1hi Tph cells are expanded in other autoimmune and inflam-
matory diseases.
CONCLUSiON
Compelling data now demonstrate the key role of the Tfh in 
B  cell responses, both protective and pathogenic. Much still 
remains to be learned. For example, we do not know whether the 
subsets we have identified represent activation or differentiation 
states, and whether there is phenotypic and functional plasticity 
among any of these subsets. We do not know how Tph relate to 
Tfh and whether and how they contribute to tissue inflammation. 
We need to learn whether uncontrolled antibody responses relate 
to an expanded Tfh number or an altered Tfh repertoire and we 
need to learn if Tfh selectively respond to particular antigens. 
The field is rapidly growing and answers to these, and answers 
to these questions, and more, are likely to be forthcoming and to 
suggest strategies for treatment of both autoimmune diseases and 
immunodeficiency states.
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